Publications by authors named "Riita Parkkola"
Article Synopsis
- The research aimed to explore the relationship between liver fat content (LFC) and hepatic glucose uptake (HGU) in patients with type 2 diabetes and how these change with rosiglitazone treatment.
- Diabetic patients showed lower HGU and higher LFC compared to healthy individuals, with a significant inverse correlation between LFC and HGU.
- After 16 weeks, rosiglitazone treatment reduced LFC and increased HGU; however, the changes in these two measures were not directly related, indicating that the drug's effects on liver metabolism operate through different mechanisms, such as reduced levels of nonesterified fatty acids.
